Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Dr Jones noted that cryoprecipitate was the treatment of choice for haemophiliacs, but when not available FFP would be used.

  • Read more about Dr Jones noted that cryoprecipitate was the treatment of choice for haemophiliacs, but when not available FFP would be used.

Dr Jones told his patients that a substantial proportion of those infected with NANBH would develop liver disease

  • Read more about Dr Jones told his patients that a substantial proportion of those infected with NANBH would develop liver disease

Dr Jones suggested that the Newcastle centre's policy was to encourage both home and prophylaxis treatment.

  • Read more about Dr Jones suggested that the Newcastle centre's policy was to encourage both home and prophylaxis treatment.

Dr Jones stated that the introduction of concentrates allowed the development of home therapy and eventually prophylactic treatment.

  • Read more about Dr Jones stated that the introduction of concentrates allowed the development of home therapy and eventually prophylactic treatment.

Dr Jones suggested in his statement to the Inquiry, that cryoprecipitate was the treatment of choice until 1973, "when sufficient Factor VIII became available".

  • Read more about Dr Jones suggested in his statement to the Inquiry, that cryoprecipitate was the treatment of choice until 1973, "when sufficient Factor VIII became available".

In a letter from Dr Jones to Dr Sackwood, it was noted that 23 patients were on home therapy in the Newcastle area.

  • Read more about In a letter from Dr Jones to Dr Sackwood, it was noted that 23 patients were on home therapy in the Newcastle area.

Dr Jones' "Guidelines for the Organisation of a Haemophilia Centre" recorded that "within our geographical region, which has a population of 3.3 million, the home therapy programme is run from the Newcastle Centre and all patients are followed up there by the core team."

  • Read more about Dr Jones' "Guidelines for the Organisation of a Haemophilia Centre" recorded that "within our geographical region, which has a population of 3.3 million, the home therapy programme is run from the Newcastle Centre and all patients are followed up there by the core team."

Dr Peter Jones was joined by Dr Peter Hamilton as co-director of the Newcastle Haemophilia Centre.

  • Read more about Dr Peter Jones was joined by Dr Peter Hamilton as co-director of the Newcastle Haemophilia Centre.

Dr Peter Jones suggested AIDS in haemophilia patients was brought to the attention of haemophilia centre directors by Professor Bloom at a meeting of the Haemophilia Reference Centre Directors.

  • Read more about Dr Peter Jones suggested AIDS in haemophilia patients was brought to the attention of haemophilia centre directors by Professor Bloom at a meeting of the Haemophilia Reference Centre Directors.

Dr Peter Jones had no doubt that haemophiliacs exposed to multi donor concentrates were infected with non-A non-B hepatitis and that a substantial number would go on to develop chronic liver disease.

  • Read more about Dr Peter Jones had no doubt that haemophiliacs exposed to multi donor concentrates were infected with non-A non-B hepatitis and that a substantial number would go on to develop chronic liver disease.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 82
  • Page 83
  • Page 84
  • Page 85
  • Current page 86
  • Page 87
  • Page 88
  • Page 89
  • Page 90
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.